Literature DB >> 31597697

NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation.

Su-Ho Park1, Sunyoung Ham2,3, Arim Lee1, Andreas Möller2,3, Tae Sung Kim4.   

Abstract

Naïve CD4+ T cells in the periphery differentiate into regulatory T cells (Tregs) in which Foxp3 is expressed for their suppressive function. NLRP3, a pro-inflammatory molecule, is known to be involved in inflammasome activation associated with several diseases. Recently, the expression of NLRP3 in CD4+ T cells, as well as in myeloid cells, has been described; however, a role of T cell-intrinsic NLRP3 in Treg differentiation remains unknown. Here, we report that NLRP3 impeded the expression of Foxp3 independent of inflammasome activation in Tregs. NLRP3-deficient mice elevate Treg generation in various organs in the de novo pathway. NLRP3 deficiency increased the amount and suppressive activity of Treg populations, whereas NLRP3 overexpression reduced Foxp3 expression and Treg abundance. Importantly, NLRP3 interacted with Kpna2 and translocated to the nucleus from the cytoplasm under Treg-polarizing conditions. Taken together, our results identify a novel role for NLRP3 as a new negative regulator of Treg differentiation, mediated via its interaction with Kpna2 for nuclear translocation.
© 2019 Park et al.

Entities:  

Keywords:  Inflammasome-independent pathway; Kpna2; NLRP3; T-cell biology; Treg differentiation; Western blot; cell differentiation; forkhead box P3 (FOXP3); gene knockout; immunosuppression; negative regulator; nuclear translocation; protein-protein interaction; transfection

Mesh:

Substances:

Year:  2019        PMID: 31597697      PMCID: PMC6879348          DOI: 10.1074/jbc.RA119.010545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Pyroptosis as a Regulated Form of Necrosis: PI+/Annexin V-/High Caspase 1/Low Caspase 9 Activity in Cells = Pyroptosis?

Authors:  Jun-Ichi Abe; Craig Morrell
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

Review 2.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

3.  Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations.

Authors:  Aigli G Vakrakou; Sorina Boiu; Panayiotis D Ziakas; Evangelia Xingi; Haralabia Boleti; Menelaos N Manoussakis
Journal:  J Autoimmun       Date:  2018-03-16       Impact factor: 7.094

4.  The duration of T cell stimulation is a critical determinant of cell fate and plasticity.

Authors:  Natasa Miskov-Zivanov; Michael S Turner; Lawrence P Kane; Penelope A Morel; James R Faeder
Journal:  Sci Signal       Date:  2013-11-05       Impact factor: 8.192

Review 5.  Negative regulation of NLRP3 inflammasome signaling.

Authors:  Shuzhen Chen; Bing Sun
Journal:  Protein Cell       Date:  2013-03-21       Impact factor: 14.870

6.  Molecular mechanisms of treg-mediated T cell suppression.

Authors:  Angelika Schmidt; Nina Oberle; Peter H Krammer
Journal:  Front Immunol       Date:  2012-03-21       Impact factor: 7.561

7.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

Authors:  Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

8.  Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components.

Authors:  Rongrong Liu; Agnieszka D Truax; Liang Chen; Peizhen Hu; Zengshan Li; Jun Chen; Chaojun Song; Lihua Chen; Jenny Pan-Yun Ting
Journal:  Oncotarget       Date:  2015-10-20

9.  Inflammation-induced Id2 promotes plasticity in regulatory T cells.

Authors:  Sung-Min Hwang; Garima Sharma; Ravi Verma; Seohyun Byun; Dipayan Rudra; Sin-Hyeog Im
Journal:  Nat Commun       Date:  2018-11-09       Impact factor: 14.919

10.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

Authors:  Stephan Sauer; Ludovica Bruno; Arnulf Hertweck; David Finlay; Marion Leleu; Mikhail Spivakov; Zachary A Knight; Bradley S Cobb; Doreen Cantrell; Eric O'Connor; Kevan M Shokat; Amanda G Fisher; Matthias Merkenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

View more
  12 in total

Review 1.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

Review 2.  Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity.

Authors:  Giuseppe Palma; Gian Pio Sorice; Valentina Annamaria Genchi; Fiorella Giordano; Cristina Caccioppoli; Rossella D'Oria; Nicola Marrano; Giuseppina Biondi; Francesco Giorgino; Sebastio Perrini
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

3.  USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy.

Authors:  Tao Liu; Liqiu Wang; Puping Liang; Xiaojuan Wang; Yukun Liu; Jing Cai; Yuanchu She; Dan Wang; Zhi Wang; Zhiyong Guo; Samuel Bates; Xiaojun Xia; Junjiu Huang; Jun Cui
Journal:  Cell Mol Immunol       Date:  2020-10-23       Impact factor: 22.096

4.  Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity via ROS Pathways.

Authors:  Dong Ni; TingTing Tang; Yifan Lu; Keman Xu; Ying Shao; Fatma Saaoud; Jason Saredy; Lu Liu; Charles Drummer; Yu Sun; Wenhui Hu; Jahaira Lopez-Pastrana; Jin J Luo; Xiaohua Jiang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

5.  Upregulation of Nucleotide-Binding Oligomerization Domain-, LRR- and Pyrin Domain-Containing Protein 3 in Motoneurons Following Peripheral Nerve Injury in Mice.

Authors:  Bernát Nógrádi; Ádám Nyúl-Tóth; Mihály Kozma; Kinga Molnár; Roland Patai; László Siklós; Imola Wilhelm; István A Krizbai
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

6.  Protectin DX restores Treg/Th17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a.

Authors:  Shengwei Jin; Siyuan Sun; Hanzhi Ling; Jinglan Ma; Xu Zhang; Zhen Xie; Ning Zhan; Wenjie Zheng; Man Li; Yang Qin; Heping Zhao; Yan Chen; Xinyu Yang; Jianguang Wang
Journal:  Cell Death Dis       Date:  2021-03-15       Impact factor: 8.469

7.  Immunological repertoire linked to PSTPIP1-associated myeloid-related inflammatory (PAMI) syndrome.

Authors:  Leonardo Oliveira Mendonça; Maria Teresa Terreri; Fabiane Mitie Osaku; Samar Freschi Barros; Karen Francine Köhler; Alex Isidoro Prado; Myrthes Toledo Barros; Jorge Kalil; Fabio Fernandes Morato Castro
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-16       Impact factor: 3.054

Review 8.  Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly.

Authors:  Juana Serrano-López; Beatriz Martín-Antonio
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

9.  Motoneuronal inflammasome activation triggers excessive neuroinflammation and impedes regeneration after sciatic nerve injury.

Authors:  Kinga Molnár; Bernát Nógrádi; Rebeka Kristóf; Ádám Mészáros; Krisztián Pajer; László Siklós; Antal Nógrádi; Imola Wilhelm; István A Krizbai
Journal:  J Neuroinflammation       Date:  2022-03-19       Impact factor: 8.322

10.  KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.

Authors:  Xiuzhi Zhang; Jialing Zhang; Fenglan Gao; Shasha Fan; Liping Dai; Jinzhong Zhang
Journal:  Front Genet       Date:  2020-10-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.